PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |